China Resources Pharmaceutical : PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2020 AND PROFIT ALERT OF CR SANJIU FOR THE THREE MONTHS ENDING 31 MARCH 2021 CLARIFICATION ANNOUNCEMENT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in Hong Kong with limited liability)

(Stock Code: 3320)

PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2020 AND PROFIT ALERT OF CR SANJIU FOR THE THREE MONTHS ENDING

31 MARCH 2021

CLARIFICATION ANNOUNCEMENT

Reference is made to the announcements dated 19 March 2021 (the "Announcement") of the Company in relation to the principal financial information of China Resources Sanjiu Medical & Pharmaceutical Company Limited （華潤三九醫藥股份有限公司） ("CR Sanjiu") for the year ended 31 December 2020 and profit alert of CR Sanjiu for the three months ending 31 March 2021. Unless otherwise defined herein or the context requires, capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement.

The Board wishes to clarify the term "increase" was inadvertently omitted in the table as stated on page 3 of the Announcement, and based on the preliminary assessment by the management of CR Sanjiu and the information currently available to them, the unaudited net profit attributable to the shareholders of the listed company of CR Sanjiu for the three months ending 31 March 2021 is estimated to increase from approximately RMB541.91 million to approximately RMB600 million to RMB710 million, representing year-on-year increase of approximately 10.72% to 31.02%.

Other than the above, the other information in the Announcement remains true and accurate in all material respects.

By Order of the Board

China Resources Pharmaceutical Group Limited

WANG Chuncheng

Chairman

Shenzhen, 19 March 2021

As at the date of this announcement, the Board comprises Mr. WANG Chuncheng as chairman and non-executive Director, Mr. HAN Yuewei, Mr. LI Xiangming and Mdm. WENG Jingwen as executive Directors, Mr. YU Zhongliang, Mdm. GUO Wei, Mr. WANG Shouye and Mr. LYU Ruizhi as non-executive Directors and Mdm. SHING Mo Han Yvonne, Mr. KWOK Kin Fun, Mr. FU Tingmei and Mr. ZHANG Kejian as independent non-executive Directors.